Tong Ren Tang Technologies Co ( (HK:1666) ) has shared an update.
Tong Ren Tang Technologies Co. Ltd. reported its annual results for 2024, showing a revenue increase of 7.18% to RMB7.26 billion, despite a net profit decline of 10.62% to RMB886.93 million. The company faced challenges due to rising raw material costs and declining sales in the Chinese medicine industry but responded by adjusting marketing strategies and optimizing operations to enhance market competitiveness.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in China, specializing in the Chinese medicine industry. The company focuses on producing and distributing traditional Chinese medicinal products, with a strong emphasis on innovation and market expansion.
YTD Price Performance: 1.54%
Average Trading Volume: 800
Technical Sentiment Signal: Hold
Current Market Cap: $843.3M
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.